文献速递消化道肿瘤与早癌消化内镜

结直肠癌家族史与结直肠肿瘤风险:系统综述与荟萃分析

Family History of Colorectal Cancer and the Risk of Colorectal Neoplasia: A Systematic Review and Meta-Analysis.
PubMed 文献 · Am J Gastroenterol · 2024-10-09

该系统综述与荟萃分析检索了PubMed、Web of Science和Embase从建库至2024年5月9日的观察性研究,纳入75项研究(931,515名参与者),评估一级亲属结直肠癌家族史与结直肠肿瘤(除结直肠癌外)风险的关联。结果显示,家族史与腺瘤(汇总OR 1.67,95%CI 1.46-1.91)、非进展期腺瘤(汇总OR 1.35,95%CI 1.21-1.51)、进展期腺瘤(汇总OR 1.66,95%CI 1.46-1.88)及进展期肿瘤(汇总OR 1.58,95%CI 1.44-1.73)风险升高相关;在2名或以上一级亲属患病的个体中,腺瘤(汇总OR 4.18,95%CI 1.76-9.91)、进展期腺瘤(汇总OR 2.42,95%CI 1.72-3.40)及进展期肿瘤(汇总OR 2.00,95%CI 1.68-2.38)风险更为明显。作者认为,该发现强化了对结直肠癌家族史阳性个体实施强化筛查策略的必要性和重要性。

要点

  • 一级亲属结直肠癌家族史与腺瘤、非进展期腺瘤、进展期腺瘤及进展期肿瘤风险升高相关。
  • 2名或以上一级亲属患结直肠癌时,腺瘤、进展期腺瘤及进展期肿瘤风险更为明显。
  • 作者认为该发现强化了对家族史阳性个体实施强化筛查策略的必要性和重要性。

核心结论

  • 一级亲属结直肠癌家族史与腺瘤、非进展期腺瘤、进展期腺瘤及进展期肿瘤风险升高相关,且在所有可用亚组中均持续存在。
  • 作者认为该发现进一步强化了对结直肠癌家族史阳性个体实施强化筛查策略的必要性和重要性,对相关卫生资源分配和政策制定非常有用。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、Web of Science和Embase从建库至2024年5月9日的观察性研究。
  • 共筛选5,172条初始记录,纳入75项研究(931,515名参与者),评估一级亲属结直肠癌家族史与结直肠肿瘤(除结直肠癌外)风险的关联。
  • 采用随机效应模型进行数据合成,并进行了亚组荟萃分析以评估结果的稳健性。

主要发现

  • 一级亲属结直肠癌家族史与腺瘤风险升高相关(汇总OR 1.67,95%CI 1.46-1.91)。
  • 一级亲属结直肠癌家族史与非进展期腺瘤风险升高相关(汇总OR 1.35,95%CI 1.21-1.51)。
  • 一级亲属结直肠癌家族史与进展期腺瘤风险升高相关(汇总OR 1.66,95%CI 1.46-1.88)。
  • 一级亲属结直肠癌家族史与进展期肿瘤风险升高相关(汇总OR 1.58,95%CI 1.44-1.73)。
  • 在2名或以上一级亲属患病的个体中,腺瘤(汇总OR 4.18,95%CI 1.76-9.91)、进展期腺瘤(汇总OR 2.42,95%CI 1.72-3.40)及进展期肿瘤(汇总OR 2.00,95%CI 1.68-2.38)风险更为明显。

关键数值与推荐

  • 腺瘤:汇总OR 1.67(95%CI 1.46-1.91)。
  • 非进展期腺瘤:汇总OR 1.35(95%CI 1.21-1.51)。
  • 进展期腺瘤:汇总OR 1.66(95%CI 1.46-1.88)。
  • 进展期肿瘤:汇总OR 1.58(95%CI 1.44-1.73)。
  • 2名或以上一级亲属患病:腺瘤汇总OR 4.18(95%CI 1.76-9.91),进展期腺瘤汇总OR 2.42(95%CI 1.72-3.40),进展期肿瘤汇总OR 2.00(95%CI 1.68-2.38)。

临床怎么用

  • 作者认为,该发现进一步强化了对结直肠癌家族史阳性个体实施强化筛查策略的必要性和重要性。
  • 作者认为,该发现对相关卫生资源分配和政策制定非常有用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Although there is enough pooled evidence supporting the positive association between family history of colorectal cancer (CRC) in first-degree relatives (FDRs) and the risk of CRC, synthesized data on its association with the risk of other colorectal neoplasia are lacking. Therefore, we aimed to systematically assess this issue. METHODS: We searched PubMed, Web of Science, and Embase from database inception through May 9, 2024, to identify observational studies investigating the association between family history of CRC in FDRs and the risk of colorectal neoplasia (excepting CRC). Adenoma, nonadvanced adenoma (NAA), advanced adenoma (AA), and advanced neoplasia (AN) were further chosen as main outcomes because of data availability. Random-effects model was used for data synthesis. Subgroup meta-analyses were performed to evaluate the robustness of results. RESULTS: Of 5,172 initial records screened, 75 studies (with 931,515 participants) were identified for analysis. Family history of CRC in FDRs was associated with increased risk of adenoma (pooled odds ratio [OR] 1.67, 95% confidence interval [CI] 1.46-1.91), NAA (pooled OR 1.35, 95% CI 1.21-1.51), AA (pooled OR 1.66, 95% CI 1.46-1.88), and AN (pooled OR 1.58, 95% CI 1.44-1.73). The positive associations persisted in all examined subgroups. The risk of adenoma (pooled OR 4.18, 95% CI 1.76-9.91), AA (pooled OR 2.42, 95% CI 1.72-3.40), and AN (pooled OR 2.00, 95% CI 1.68-2.38) was more evident among individuals with 2 or more affected FDRs. DISCUSSION: Family history of CRC is associated with increased risk of adenoma, NAA, AA, and AN totally, and in all available subgroups. The findings further strengthen the necessity and importance of an intensified screening strategy for individuals with a positive family history of CRC, which is very useful for related health resource allocation and policymaking.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Gao K, Jin H, Yang Y, et al. Family History of Colorectal Cancer and the Risk of Colorectal Neoplasia: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2024. PMID: 39513348. doi:10.14309/ajg.0000000000003120

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。